Nightengale Clinical Research And Consul is categorized under Business Consultants in Rosharon, TX and active since 2012.
Nightengale Clinical Research And Consul was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Brenda Fisher at the company’s single location by writing to 13805 Creekmill Court, Rosharon, Texas TX 77583 or by phoning (281) 972-9124. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nightengale Clinical Research And Consul |
| Contact Person: | Brenda Fisher |
| Address: | 13805 Creekmill Court, Rosharon, Texas 77583 |
| Phone Number: | (281) 972-9124 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Nightengale Clinical Research And Consul was started in 2012 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Brenda Fisher for inquiries that concern Nightengale Clinical Research And Consul by calling the company number (281) 972-9124, as your correspondence is most welcome. Additionally, the physical location of the single location of Nightengale Clinical Research And Consul can be found at the coordinates 29.507819,-95.436345 as well as the street address 13805 Creekmill Court in Rosharon, Texas 77583.
For its online presence, you may visit Nightengale Clinical Research And Consul’s website at and engage with its social media outlets through on Twitter and on Facebook.